1. Home
  2. RCUS vs MLCO Comparison

RCUS vs MLCO Comparison

Compare RCUS & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.08

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$6.39

Market Cap

2.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCUS
MLCO
Founded
2015
2004
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
RCUS
MLCO
Price
$23.08
$6.39
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$28.89
$9.42
AVG Volume (30 Days)
1.4M
2.1M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$240,000,000.00
$5,061,044,000.00
Revenue This Year
N/A
$13.56
Revenue Next Year
N/A
$2.49
P/E Ratio
N/A
$24.75
Revenue Growth
N/A
11.46
52 Week Low
$6.50
$4.55
52 Week High
$26.40
$10.15

Technical Indicators

Market Signals
Indicator
RCUS
MLCO
Relative Strength Index (RSI) 52.59 32.85
Support Level $20.70 $5.90
Resistance Level $23.40 $6.82
Average True Range (ATR) 1.44 0.27
MACD 0.03 -0.05
Stochastic Oscillator 61.75 27.84

Price Performance

Historical Comparison
RCUS
MLCO

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.

Share on Social Networks: